IL-2/anti-IL-2 complex (IL-2C) has been reported to rapidly increase Tregs in different diseases, including stroke, myasthenia, or atherosclerosis, and provides protective effects by inhibiting inflammation and substantially attenuating the progression of these diseases (12, 16–19). Here, IL2 is linked to Stroke.